Vitality Watch

Dossier pubmed review 01-oct-2026
Narrative review or expert overview without new data

The Role of EVs in the Aging Hematopoietic System.

Key claim: Aging remodels bone-marrow EV biogenesis and cargo—especially from senescent MSCs and osteoblasts—driving niche dysfunction, recipient senescence, and myeloid-biased hematopoiesis, while EVs from young or pluripotent stem cells can restore aged HSPC function and attenuate inflammaging.

Abstract

Extracellular vesicles (EVs) are membrane-enclosed nanoparticles that mediate intercellular communication by transferring proteins, nucleic acids, and lipids. Within the hematopoietic system, EVs orchestrate critical signaling between bone marrow (BM) niche cells and hematopoietic stem and progenitor cells (HSPCs) to regulate quiescence, proliferation, and lineage commitment. During aging, senescence and telomere attrition drive a profound remodeling of EV biogenesis and cargo. Aged EVs, particularly those released from senescent mesenchymal stromal cells (MSCs) and osteoblasts, exhibit altered microRNA profiles and reduced protective antioxidants. These changes perpetuate niche dysfunction, induce senescence in recipient cells, and promote myeloid-biased hematopoiesis. Importantly, this communication is a selective process governed by vesicle-intrinsic surface signatures, such as tetraspanins and integrins, which interact with specific receptors on distinct hematopoietic subsets to regulate signaling fidelity. Conversely, EVs from young or pluripotent stem cells deliver rejuvenating signals that can restore aged HSPC function and attenuate inflammaging. Elucidating these mechanisms of selective targeting and stress-responsive cargo remodeling provides vital insights for developing EV-based diagnostic tools and rejuvenation strategies to prevent age-related immune imbalances and hematologic malignancies.

Why this matters

Aging remodels bone-marrow EV biogenesis and cargo—especially from senescent MSCs and osteoblasts—driving niche dysfunction, recipient senescence, and myeloid-biased hematopoiesis, while EVs from young or pluripotent stem cells can restore aged HSPC function and attenuate inflammaging.

Source

Link

Briefing card

The Role of EVs in the Aging Hematopoietic System.
Stage: review · pubmed · 01-oct-2026

Aging remodels bone-marrow EV biogenesis and cargo—especially from senescent MSCs and osteoblasts—driving niche dysfunction, recipient senescence, and myeloid-biased hematopoiesis, while EVs from young or pluripotent stem cells can restore aged HSPC function and attenuate inflammaging.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1111/acel.70715

build build 880 · 2bcef25 · 2026-11-18